Immunitas Therapeutics is a startup based in the United States, most recent round Series A.
Immunitas Therapeutics is a startup based in the United States. Its most recent tracked round is Series A.
Immunitas Therapeutics uses a single cell genomics platform to study immune cell biology in human tumors, enabling the identification of novel drug targets and development of therapies guided by patient biomarkers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.